Bezafibrate 200 MG Oral Tablet ( DrugBank: Bezafibrate )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
93	原発性胆汁性胆管炎	1

93. 原発性胆汁性胆管炎

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04751188 (ClinicalTrials.gov)	October 2, 2020	5/2/2021	A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis	Safety and Efficacy of Bezafibrate Plus Ursodesoxicolic Acid in Patients With Primary Biliary Cholan ...	Primary Biliary Cirrhosis	Drug: Bezafibrate 200 MG Oral Tablet;Drug: Placebo;Drug: Ursodeoxycholic Acid	Instituto Mexicano del Seguro Social	NULL	Active, not recruiting	18 Years	65 Years	All	11	Phase 3	Mexico

First Previous1Next Last